Racial Health Disparities

Uses

How it works

Risks & contraindications

Comparisons

Evidence quality

Highlighted claims

• The review aims to inform tailored, evidence-based asthma self-management interventions to reduce asthma health inequities among minority and low-income school-aged children. — Effectiveness of self-management interventions for asthma control and healthcare utilisation among school-aged children in minority families in the United States: A protocol for systematic review and meta-analysis
• Black Non-Hispanic children have an asthma prevalence of 11.6%, well above the US national average of 6.5%. — Effectiveness of self-management interventions for asthma control and healthcare utilisation among school-aged children in minority families in the United States: A protocol for systematic review and meta-analysis
• American Indian/Alaska Native Non-Hispanic children have an asthma prevalence of 9.2%, also above the national average. — Effectiveness of self-management interventions for asthma control and healthcare utilisation among school-aged children in minority families in the United States: A protocol for systematic review and meta-analysis
• Children from low-income families face compounding disadvantages including limited healthcare access, scarce resources, adverse environmental exposures, and effects of social determinants of health. — Effectiveness of self-management interventions for asthma control and healthcare utilisation among school-aged children in minority families in the United States: A protocol for systematic review and meta-analysis
• Because the review focuses exclusively on US minority populations, findings cannot be generalised to low-SES non-minority children. — Effectiveness of self-management interventions for asthma control and healthcare utilisation among school-aged children in minority families in the United States: A protocol for systematic review and meta-analysis
• No statistically significant adjusted differences in MALO odds were found for Hispanic, Asian, Native American, or other racial groups compared with white patients. — Racial and Socioeconomic Determinants of Major Adverse Liver Outcomes in Patients with Coexisting Inflammatory Bowel Disease and Chronic Liver Disease: Insights from the National Inpatient Sample
• Hepatocellular carcinoma occurred more frequently among African American patients (1.25%) and Hispanic patients (0.95%) than in other racial groups. — Racial and Socioeconomic Determinants of Major Adverse Liver Outcomes in Patients with Coexisting Inflammatory Bowel Disease and Chronic Liver Disease: Insights from the National Inpatient Sample
• Hispanic patients in the IBD cohort had a fourfold higher incidence of hepatocellular carcinoma compared with white patients. — Racial and Socioeconomic Determinants of Major Adverse Liver Outcomes in Patients with Coexisting Inflammatory Bowel Disease and Chronic Liver Disease: Insights from the National Inpatient Sample
• Hispanic patients were more represented in the IBD-CLD group than in the IBD-only group (10.72% vs 8.20%). — Racial and Socioeconomic Determinants of Major Adverse Liver Outcomes in Patients with Coexisting Inflammatory Bowel Disease and Chronic Liver Disease: Insights from the National Inpatient Sample
• Prior evidence indicates Hispanic patients with HCC have higher incidence, later-stage diagnosis, and lower likelihood of curative treatment or transplantation. — Racial and Socioeconomic Determinants of Major Adverse Liver Outcomes in Patients with Coexisting Inflammatory Bowel Disease and Chronic Liver Disease: Insights from the National Inpatient Sample